Panagora Asset Management’s AYTU BioPharma AYTU Stock Holding History

Panagora Asset Management’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-137	Closed	-$21K	–	2776
2021 Q1	$21K	Buy	+137	New	+$21.7K	﹤0.01%	2304

Other funds holding AYTU

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Panagora Asset Management's AYTU Position: Q2 2021 in Review

Panagora Asset Management sold out of AYTU BioPharma (AYTU) in Q2 2021, closing a stake of 137 shares — an estimated $21K sold.

Panagora Asset Management first reported a position in AYTU in Q1 2021 and held it in 1 quarter. The position peaked at $21K in Q1 2021. 50 funds tracked by Wall St. Rank hold AYTU as of Q2 2021.

Panagora Asset Management reported no remaining AYTU BioPharma position as of Q2 2021 after selling out during the quarter.
Panagora Asset Management sold 137 AYTU BioPharma shares in Q2 2021, an estimated $21K.
Panagora Asset Management first reported a position in AYTU BioPharma in Q1 2021 and held it in 1 quarter.
Panagora Asset Management's AYTU BioPharma position peaked at $21K in Q1 2021.
50 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.